Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression G Ren, J Su, L Zhang, X Zhao, W Ling, A L'huillie, J Zhang, Y Lu, ... Stem cells 27 (8), 1954-1962, 2009 | 754 | 2009 |
How mesenchymal stem cells interact with tissue immune responses Y Shi, J Su, AI Roberts, P Shou, AB Rabson, G Ren Trends in immunology 33 (3), 136-143, 2012 | 714 | 2012 |
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair Y Shi, G Hu, J Su, W Li, Q Chen, P Shou, C Xu, X Chen, Y Huang, Z Zhu, ... Cell research 20 (5), 510-518, 2010 | 708 | 2010 |
Mesenchymal stem cells: a double-edged sword in regulating immune responses W Li, G Ren, Y Huang, J Su, Y Han, J Li, X Chen, K Cao, Q Chen, P Shou, ... Cell Death & Differentiation 19 (9), 1505-1513, 2012 | 506 | 2012 |
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species J Su, X Chen, Y Huang, W Li, J Li, K Cao, G Cao, L Zhang, F Li, ... Cell Death & Differentiation 21 (3), 388-396, 2014 | 261 | 2014 |
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy X Du, F Tang, M Liu, J Su, Y Zhang, W Wu, M Devenport, CA Lazarski, ... Cell research 28 (4), 416-432, 2018 | 234 | 2018 |
The interaction between mesenchymal stem cells and steroids during inflammation X Chen, Y Gan, W Li, J Su, Y Zhang, Y Huang, AI Roberts, Y Han, J Li, ... Cell death & disease 5 (1), e1009-e1009, 2014 | 110 | 2014 |
Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice X Du, M Liu, J Su, P Zhang, F Tang, P Ye, M Devenport, X Wang, Y Zhang, ... Cell research 28 (4), 433-447, 2018 | 108 | 2018 |
Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-γ and nitric oxide G Ren, J Su, X Zhao, L Zhang, J Zhang, AI Roberts, H Zhang, G Das, ... The Journal of Immunology 181 (5), 3277-3284, 2008 | 83 | 2008 |
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation Y Huang, P Yu, W Li, G Ren, AI Roberts, W Cao, X Zhang, J Su, X Chen, ... Oncogene 33 (29), 3830-3838, 2014 | 71 | 2014 |
间充质干细胞免疫抑制机制及在疾病中的应用 寿培舜, 黄寅, 苏娟娟, 陈箐, 李文钊, 田新莉, 许光武, 任光文, ... 细胞生物学杂志 31 (1), 15-20, 2009 | 10 | 2009 |
Established thymic epithelial progenitor/stem cell-like cell lines differentiate into mature thymic epithelial cells and support T cell development P Chen, J Zhang, Y Zhan, J Su, Y Du, G Xu, Y Shi, U Siebenlist, X Zhang PloS one 8 (9), e75222, 2013 | 5 | 2013 |
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4–and PD-1–targeted immunotherapy M Liu, X Wang, X Du, W Wu, Y Zhang, P Zhang, C Ai, M Devenport, J Su, ... Science translational medicine 15 (685), eabm5663, 2023 | 3 | 2023 |
Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease C Bailey, Y Wei, J Yan, D Huang, P Zhang, C Qi, C Lazarski, JJ Su, ... Cell Reports Medicine 4 (11), 2023 | 1 | 2023 |
Correction: Established Thymic Epithelial Progenitor/Stem Cell-Like Cell Lines Differentiate into Mature Thymic Epithelial Cells and Support T Cell Development P Chen, J Zhang, Y Zhan, J Su, Y Du, G Xu, Y Shi, U Siebenlist, X Zhang Plos one 8 (11), 2013 | | 2013 |
Translating Stem Cell Research into Patient Care: Hype or Reality? PD Yufang Shi, Ph.D.*, Xiaodong Chen, B.Med., Liying Zhang, B.Med., Juanjuan ... The 2011 Sino-American symposium on clinical and translational medicine, 2011 | | 2011 |
Immunomodulatory properties of mesenchymal stem cells X HUANG, X HAN, Y HONG, J SU, X TIAN, Q CHEN, W LI, P SHOU, ... Chinese Bulletin of Life Sciences, 2009 | | 2009 |
Targeting HIF1α in Bone Marrow Transplant Allows Combo-Immunotherapy to Boost Graft vs Leukemia Effect Without Exacerbation Graft vs Host Disease C Bailey, Y Wei, J Yan, D Huang, P Zhang, C Qi, CA Lazarski, JJ Su, ... | | |